Trial reportBMC ophthalmology2026
Effect of shorter silicone oil tamponade time on visual function recovery and associated factors in patients with rhegmatogenous retinal detachment.
Trial report in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThere were no standardized clinical criteria for the duration of silicone oil (SO) tamponade for rhegmatogenous retinal detachment (RRD). This study aimed to investigate the effect of shorter SO tamponade time on visual function recovery in patients treated with a 2-month SO tamponade (Group A) compared to a 4-month SO tamponade (Group B) for RRD.
methodsThis is a prospective randomized controlled study. A total of 67 patients were included, 34 in Group A, and 33 in Group B. Best corrected visual acuity (BCVA), complications, inflammatory cytokine in aqueous humor, electrolyte levels, choroidal vascularity index (CVI), and choroidal thickness (CT) were measured at the timing of 1 week before SO removal (before SOR) and 3 months after SOR (after SOR).
resultsAfter SOR, Group A showed better BCVA (P = 0.002), lower SO emulsification rate (P < 0.001), and lower level of IL-1β than Group B (P = 0.016); other inflammatory factors were not statistically significant between the two groups. BCVA after SOR was better than before SOR in Group A (P < 0.001). Group B CVI before SOR was lower than after SOR (P = 0.013). When the two groups were analyzed together, BCVA after SOR was significantly improved compared with that before SOR (P < 0.001), and CVI after SOR was also significantly higher (P = 0.021); the difference in the electrolytes, CT, and CVI between the two groups was not statistically significant.
conclusionsA 2-month SO tamponade compared with a 4-month SO tamponade for RRD can improve visual function and reduce inflammatory factors and SO emulsification after successful retinal attachment. Compared with before SOR, patients after SOR had higher BCVA and higher CVI.
trial registrationRegistration date:24/04/2022; Registration number: ChiCTR2200059077; Registration site: Chinese Clinical Trial Registry (ChiCTR).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.